| Also Known as (Alias) |
Anti-HTLV-I/II Confirmatory |
| Indications |
Confirmatory testing performed due to a reactive PRISM or Avioq-HTLV-I/II result. |
| Method |
MP Diagnostics HTLV Blot 2.4 Western Blot Assay |
| Test Information |
Assay is a qualitative immunoassay intended for confirming the presence of and differentiating antibodies to Human T-Lymphotropic Virus Type I and/or Human T-Lymphotropic Virus Type II in human serum or plasma with repeatedly reactive results by an FDA licensed HTLV-I/-II donor screening test. |
| Sample Requirements |
Serum or Plasma (EDTA, heparin, sodium citrate, PPT, potassium oxalate or ACD) |
| Requested Volume |
6 mL |
| Minimum Volume or Pediatric volume |
1 mL |
| Shipping Information |
Samples are acceptable at 2-8°C for 7 days; samples may be frozen at -20 °C |
| Requisition Form |
Donor Testing RFT |
| Transaction Code |
3076-03 |
| CPT Codes |
86689 |
| Test Schedule |
Every 2-3 weeks |
| Turn around Time (analytic time) |
Varied, depending on batch size |
| Report/ Results |
Seronegative, HTLV-I Seropositive, HTLV-II Seropositive, HTLV-I/II Seropositive, Indeterminate, Unreadable |
